364 related articles for article (PubMed ID: 33103803)
1. Emerging Immunotherapies in the Treatment of Brain Metastases.
Nieblas-Bedolla E; Nayyar N; Singh M; Sullivan RJ; Brastianos PK
Oncologist; 2021 Mar; 26(3):231-241. PubMed ID: 33103803
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
3. Immune Therapy for Central Nervous System Metastasis.
McAvoy MB; Choi BD; Jones PS
Neurosurg Clin N Am; 2020 Oct; 31(4):627-639. PubMed ID: 32921357
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
5. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
6. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
7. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
8. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of brain metastases: breaking a "dogma".
Di Giacomo AM; Valente M; Cerase A; Lofiego MF; Piazzini F; Calabrò L; Gambale E; Covre A; Maio M
J Exp Clin Cancer Res; 2019 Oct; 38(1):419. PubMed ID: 31623643
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Immunotherapy-Update 2019.
Hamid O; Ismail R; Puzanov I
Oncologist; 2020 Mar; 25(3):e423-e438. PubMed ID: 32162802
[TBL] [Abstract][Full Text] [Related]
12. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
13. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
Pennock GK; Chow LQ
Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
[TBL] [Abstract][Full Text] [Related]
14. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.
Gray SG
BMC Pulm Med; 2021 May; 21(1):148. PubMed ID: 33952230
[TBL] [Abstract][Full Text] [Related]
15. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.
Haddad AF; Young JS; Mummaneni NV; Kasahara N; Aghi MK
J Neurooncol; 2021 Mar; 152(1):1-13. PubMed ID: 33389564
[TBL] [Abstract][Full Text] [Related]
16. Anti-PD-(L)1 immunotherapy for brain metastases in non-small cell lung cancer: Mechanisms, advances, and challenges.
Zhou S; Xie J; Huang Z; Deng L; Wu L; Yu J; Meng X
Cancer Lett; 2021 Apr; 502():166-179. PubMed ID: 33450361
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.
Lazaro T; Brastianos PK
CNS Oncol; 2017 Apr; 6(2):139-151. PubMed ID: 28425754
[TBL] [Abstract][Full Text] [Related]
18. The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.
Nejo T; Mende A; Okada H
Jpn J Clin Oncol; 2020 Oct; 50(11):1231-1245. PubMed ID: 32984905
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
20. [Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC].
Lan Q; Ji C; Yao Y
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):512-519. PubMed ID: 31451142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]